Non-Hodgkin's lymphoma of the oral cavity and maxillofacial region: a pathologist viewpoint.
Abdelwahed Hussein MR.
Expert Rev Hematol. 2018 Sep;11(9):737-748. doi: 10.1080/17474086.2018.1506326. Epub 2018 Aug 21.
Systematic review of lymphoma in oral cavity and maxillofacial region.
Guevara-Canales JO, Morales-Vadillo R, de Faria PE, Sacsaquispe-Contreras SJ, Leite FP, Chaves MG.
Acta Odontol Latinoam. 2011;24(3):245-50.
Non-Hodgkin's lymphoma: A review.
Singh R, Shaik S, Negi BS, Rajguru JP, Patil PB, Parihar AS, Sharma U.
J Family Med Prim Care. 2020 Apr 30;9(4):1834-1840. doi: 10.4103/jfmpc.jfmpc_1037_19. eCollection 2020 Apr.
Acute lymphoblastic leukemia/lymphoma of the oral and maxillofacial region.
Sánchez-Romero C, Pontes HAR, Pontes FSC, Rocha AC, Carlos R, Rendón JC, de Almeida OP, Fonseca FP.
Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Aug;126(2):152-164. doi: 10.1016/j.oooo.2018.01.010. Epub 2018 Jan 31.
Mantle cell lymphoma involving the oral and maxillofacial region: a study of 20 cases.
Carvalho MVR, Rodrigues-Fernandes CI, de Cáceres CVBL, Mesquita RA, Martins MD, Román Tager EMJ, Carlos R, Pires FR, Robinson L, van Heerden WFP, Valente VB, Xavier-Júnior JCC, Bernabé DG, Pontes HAR, Soares CD, da Costa MHM, Vargas PA, Fonseca FP.
Oral Surg Oral Med Oral Pathol Oral Radiol. 2023 Jan;135(1):101-109. doi: 10.1016/j.oooo.2022.08.018. Epub 2022 Sep 7.
Clinicopathological and genetic characteristics of diffuse large B-cell lymphoma of the oropharyngeal and maxillofacial region.
Xia S, Yue J, Chen X, Hu Y, Guo F, Zhang J.
Oral Dis. 2021 Apr;27(3):448-456. doi: 10.1111/odi.13578. Epub 2020 Aug 20.
Management of Non-Hodgkin's Lymphoma in Maxillofacial Region with Chemotherapy.
Moin A, Shetty AD.
Ann Maxillofac Surg. 2017 Jul-Dec;7(2):312-315. doi: 10.4103/ams.ams_85_17.
Management of an extensive odontogenic keratocyst: A rare case report with 10-year follow-up.
Khan AA, Qahtani SA, Dawasaz AA, Saquib SA, Asif SM, Ishfaq M, Kota MZ, Ibrahim M.
Medicine (Baltimore). 2019 Dec;98(51):e17987. doi: 10.1097/MD.0000000000017987.
EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1.
Wang J, Ge J, Wang Y, Xiong F, Guo J, Jiang X, Zhang L, Deng X, Gong Z, Zhang S, Yan Q, He Y, Li X, Shi L, Guo C, Wang F, Li Z, Zhou M, Xiang B, Li Y, Xiong W, Zeng Z.
Nat Commun. 2022 Feb 14;13(1):866. doi: 10.1038/s41467-022-28479-2.
Malignant Lymphoproliferative Disorders of the Oral and Maxillofacial Region: Report of Two Institutions.
Flores-Hidalgo A, Bankhead A, Murrah V, Padilla R.
Front Oral Health. 2022 Feb 3;3:802555. doi: 10.3389/froh.2022.802555. eCollection 2022.
